Vnitr Lek 2007, 53(10):1033-1034

Lékové stenty - pro všechny, pro někoho, či pro nikoho? - editorial

V. Kočka*, P. Widimský
III. interní kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC

Received: February 9, 2007; Published: October 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kočka V, Widimský P. Lékové stenty - pro všechny, pro někoho, či pro nikoho? - editorial. Vnitr Lek. 2007;53(10):1033-1034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Presented by E. Camenzind at ESC September 2006 and TCT October 2006.
    2. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting versus bare metal stents in coronary artery disease: a metaanalysis. Eur Heart J 2006; 27: 2784-2814. Go to original source... Go to PubMed...
    3. Holmes DR, Moses JW, Schofer J et al. Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J 2006; 27: 2815-2822. Go to original source... Go to PubMed...
    4. Wijns WC, Krucoff MW. Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? Eur Heart J 2006; 27: 2737-2739. Go to original source... Go to PubMed...
    5. US FDA Circulatory System Devices Panel meeting on December 7-8 2006, dostupné na http://www.fda.gov/ohrms/dockets/ac/cdrh06.html
    6. Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients with Coronary Artery Stents. AHA/ACC/SCAI/ACS/ADA Science Advisory. Dostupné na www.acc.org, v tisku bude v Circulation 2007; 2.
    7. Iakovou I et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. Go to original source... Go to PubMed...
    8. Jeremias A et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109: 1930-1932. Go to original source... Go to PubMed...
    9. Kastrati A et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005; 293: 165-171. Go to original source... Go to PubMed...
    10. Holmes DR et al. Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents. The SISR Randomized Trial. JAMA 2006; 295: 1264-1273. Go to original source... Go to PubMed...
    11. Varvařovský I, Matějka J, Herman A. Pozdní trombóza koronárního stentu a klopidogrel. Vnitř Lék 2007; 53(10): 1085-1091. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.